Multifocal high-grade glioma radiotherapy safety and efficacy

Radiation Oncology

Table 1 Patient characteristics

Pat	Age	Sex	Diag	WHO	IDH	MGMT	Resection	KPS pre RT	KPS post RT
1	50	Male	GB	IV	IDH WT	unmeth	biopsy	70	70
2	84	Male	GB	IV	IDH WT	meth	biopsy	80	80
3	68	Male	GB	IV	IDH WT	meth	biopsy	80	70
4	70	Male	GB	IV	IDH WT	meth	biopsy	90	90
5	74	Female	GB	IV	IDH WT	meth	biopsy	60	50
6	62	Male	GB	IV	IDH WT	unmeth	biopsy	90	80
7	63	Male	GB	IV	IDH WT	meth	biopsy	90	80
8	50	Female	GB	IV	IDH WT	unmeth	biopsy	90	80
9	68	Male	GB	IV	IDH WT	unmeth	biopsy	60	50
10	64	Female	GB	IV	IDH WT	unmeth	biopsy	80	70
11	53	Male	GB	IV	IDH WT	unmeth	str	90	80
12	50	Male	GB	IV	IDH WT	unmeth	biopsy	90	80
13	57	Female	AA	III	IDH WT	meth	biopsy	90	70
14	42	Female	GB	IV	IDH WT	meth	biopsy	80	70
15	62	Male	GB	IV	IDH WT	meth	gtr	100	100
16	50	Female	GB	IV	IDH WT	meth	biopsy	50	50
17	57	Male	GB	IV	IDH WT	meth	biopsy	100	100
18	54	Female	GB	IV	IDH WT	meth	biopsy	70	70
19	60	Male	GB	IV	IDH WT	unmeth	biopsy	70	80
20	69	Male	GB	IV	IDH WT	unmeth	biopsy	100	90

ISSN: 1748-717X